Pfizer, Pharmaceutical company

United States-based pharmaceutical giant Pfizer has begun testing multiple versions of an experimental vaccine in healthy young people in America.Pfizer has partnered with Germany's BioNTech SE to explore a potential defense against the respiratory disease over 2.5 lakh people worldwide, Wall Street Journal reported.Researchers at the New York University Grossman School of Medicine in Manhattan and the University of Maryland School of Medicine in Baltimore on Tuesday said that they have begun injecting volunteers with the first of four vaccine candidates from Pfizer and Germany's BioNTech.The trial began by administering the first five vaccinations to people Monday. The vaccine uses a gene-based technology known as messenger RNA.The trial has begun with healthy, young people between the ages of 18 and 55. But as safety is established in that population, it will expand to an older group of study participants -- people up to age 85The trial will help the researchers to evaluate that the vaccine candidates are safe, which produces the strongest immune response that could fend off the coronavirus and what the doses should be.The study is being conducted on 360 people whose results could come as early as next months. However, the vaccine will still need to undergo additional testing in more patients, said Kathrin Jansen, Pfizer's head of vaccine research and development.Jansen said that they will track the progress of the study to pick the most promising vaccine candidate.Pfizer Chief Executive Albert Bourla told The Wall Street Journal last week that a vaccine against coronavirus could be ready for emergency use as early as the falls if everything goes well.Several potential coronavirus vaccines have entered human testing, including candidates from Moderna Inc. and Oxford University.( With inputs from ANI )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Marathi Language Controversy

Maharashtra News

Mumbai Local

Weather Update

Mumbai Rains

Ahmedabad Plane Crash

PfizerFOLLOW

Pfizer, Latest News

Health :These Covid-19 vaccine candidates in late stage clinical trials

New York, July 28 Amid the race to develop an effective vaccine against Covid-19 in record time, six ... ...

Health :Pfizer, BioNTech start late stage clinical trial of Covid vaccine

US-based Pfizer and German biotech firm BioNTech have announced the start of a late stage clinical trial of a ... ...

International :COVID-19 vaccine will be ready by year end in 'best case scenario': Pfizer

New York, July 23 Pfizer, which has struck a nearly $2 billion deal with the US government to ... ...

Health :UK signs deals for 90mn COVID-19 vaccine doses

London, July 20 The UK government has signed deals for 90 million doses of promising coronavirus vaccines that ... ...

International :Coronavirus: How 'circuit breaker' Singapore searches for treatment, vaccine

It has been about two months since the World Health Organisation (WHO) declared Covid-19 a global pandemic on March 11. ...

International :Potential coronavirus vaccine enters human testing in US

United States-based pharmaceutical giant Pfizer has begun testing multiple versions of an experimental vaccine in healthy young people in America.Researchers at the New York University Grossman School of Medicine in Manhattan and the University of Ma ...